KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $3.7 million.

  • TherapeuticsMD's Prepaid Assets fell 161.21% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 161.21%. This contributed to the annual value of $3.6 million for FY2024, which is 983.89% down from last year.
  • Per TherapeuticsMD's latest filing, its Prepaid Assets stood at $3.7 million for Q3 2025, which was down 161.21% from $3.6 million recorded in Q2 2025.
  • TherapeuticsMD's Prepaid Assets' 5-year high stood at $10.4 million during Q3 2021, with a 5-year trough of $3.6 million in Q4 2024.
  • Moreover, its 5-year median value for Prepaid Assets was $5.0 million (2023), whereas its average is $5.9 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 2672.05% in 2022, then crashed by 5558.79% in 2023.
  • TherapeuticsMD's Prepaid Assets (Quarter) stood at $5.9 million in 2021, then rose by 2.99% to $6.0 million in 2022, then plummeted by 33.13% to $4.0 million in 2023, then fell by 9.84% to $3.6 million in 2024, then increased by 2.34% to $3.7 million in 2025.
  • Its Prepaid Assets stands at $3.7 million for Q3 2025, versus $3.6 million for Q2 2025 and $3.8 million for Q1 2025.